Evaluating Extracorporeal Membrane Oxygenation and Ventilation Treatment of Patients with COVID-19: A Review

Abstract

The prevalence of COVID-19 in the world is rapidly increasing. Although some patients show mild symptoms of the virus, some others need special care due to the exacerbation of the disease. Therefore, invasive treatments are needed to treat these patients. Data were collected from PubMed and Google scholars at various time points up to the 2020 academic year. The related keywords are listed as follows: "COVID-19", "Treatment", "Pathogenesis", and "Lung disorder". Studies have shown that although the use of ECMO and ventilation can provide oxygen to patients and improve their clinical status; these procedures can lead to the activation of inflammatory responses and the activation of the renin-angiotensin system. Inflammation and activation of the renin-angiotensin system are among the weak prognoses for COVID-19-infected patients. ECMO and ventilation treatment procedures are like double-edged swords, and monitoring patients during treatment is essential to prevent renin-angiotensin activation. *Corresponding Author: Zahra Gatavizadeh; Email: z-gatavizadeh@ajums.ac.ir Please cite this article as: Hybar H, Samimi A, Maniati M, Jodat J, Gatavizadeh Z. Evaluating Extracorporeal Membrane Oxygenation and Ventilation Treatment of Patients with COVID-19: A Review. Arch Med Lab Sci. 2020;6:1-6 (e16). https://doi.org/10.22037/amls.v6.33550